InvestorsHub Logo
icon url

CATTDOGG12347

08/21/17 11:33 AM

#30547 RE: DewDiligence #30546

I'm think BMY came around to look at the prostate results and stayed to talk about possibilities. If prostate results are looking even better then combo cervical I think we opted to go with BMY instead of AZN. After all Opdivo is basically Keytruda.
icon url

Simple Steve

08/21/17 11:44 AM

#30553 RE: DewDiligence #30546

That's what I'm afraid of too. There's got to be a reason for investors' lack of interest in ADXS. And ADXS's silence doesn't make me feel any better. They need to put out good news, the soon the better.
icon url

ignatiusrielly35

08/21/17 11:53 AM

#30554 RE: DewDiligence #30546

Please explain, Dew. I've never understood the logic of your conclusion that AZN backed away.